Ajouter à une liste

Instrument Inactif

Communiqués Agennix AG

Actions

Recherche biotechnologique et médicale

Communiqués

22/10/18	Agennix AG i.L.: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	EQ
17/05/10	AGENNIX : Announces Presentation of New Data from Talactoferrin Randomized, Double-Blind, Placebo-Controlled Phase II Trial in Severe Sepsis at American Thoracic Society International Conference	GL
14/05/10	AGENNIX : to Present at BioEquity Conference	GL
12/05/10	AGENNIX : Announces Upcoming Data Presentation from Talactoferrin Phase 2 Trial in Severe Sepsis at American Thoracic Society International Conference on May 17	GL
06/05/10	AGENNIX : Reports Financial Results for First Quarter of 2010	GL
30/04/10	AGENNIX : Schedules Conference Call on May 6, 2010 to Discuss First Quarter 2010 Financial Results	GL
24/03/10	AGENNIX : Reports Financial Results For Fiscal Year 2009	GL
22/03/10	AGENNIX : Schedules Conference Call on March 24, 2010 to Discuss Year-End 2009 Financial Results	GL
21/03/10	AGENNIX : Raises EUR 9.8 Million (~$13 Million) in Private Placement with Existing Shareholders	GL
21/03/10	AGENNIX : Ad hoc:Agennix AG:Ad hoc: Agennix AG Raises EUR 9.8 Million (~$13 Million) in Private Placement with Existing Shareholders	GL
26/02/10	AGENNIX : Announces Longer-Term Mortality Results from Talactoferrin Phase 2 Trial in Severe Sepsis	GL
10/02/10	AGENNIX : Announces U.S. Class Action Lawsuit Against Predecessor GPC Biotech AG Fully Closed	GL
02/02/10	AGENNIX : to Present at Close Brothers Seydler Small and Mid Cap Conference in Frankfurt on February 4	GL
01/12/09	AGENNIX : Announces Positive Results with Talactoferrin In Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial	GL
23/11/09	AGENNIX : Reports Financial Results For Third Quarter and First Nine Months of 2009	GL
17/11/09	AGENNIX : Schedules Conference Call on November 23rd to Discuss Third Quarter 2009 Financial Results	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Espace mes listes

Palmarès

Suite du Palmarès

Palmarès

Suite du Palmarès

Devises / Forex

Matières Premières

Cryptomonnaies

Taux d'Intérêts

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !